esmo 2020 highlights on neoadjuvant ici in early tnbc: the impassion031 study
Published 4 years ago • 1.8K plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
2:12
esmo 2020 highlights on adjuvant osimertinib for egfr mutated nsclc: the adaura study
-
5:07
esmo 2020 expert video report on 1st line ici for gastro oesophageal cancer
-
3:05
esmo 2020 highlights on sacituzumab govitecan in metastatic tnbc: the ascent study
-
2:46
#esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
3:11
esmo 2020 highlights on pembrolizumab in la-hnscc: the gortec 2015-01 “pembrorad” study
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
6:37
highlights from esmo 2020 in gynecological cancers
-
35:16
highlights from esmo 2020
-
0:29
adjuvant treatment for high risk hr breast cancer | esmo 2023 breast cancer highlights
-
3:21
esmo 2020 highlights on pembrolizumab as 1st line therapy for auc: the keynote-361 study
-
10:09
esmo 2020 expert video report on long term ici outcomes in lung cancer
-
2:45
esmo 2020 highlights on neoadjuvant mfolfirinox for t3-4 rectal cancer: the prodige 23 study
-
1:06
lung cancer highlights from esmo 2022
-
18:38
breast cancer esmo 2024 highlights: key studies discussed natalee, keynote 522, destiny-breast12
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
2:30
#esmo22 highlights on first-line atezolizumab in nsclc not eligible for platinum: the ipsos study